Speaker illustration

Doctor Mark Sweeney

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

Real world data using sacubitril/valsartan in CKD stage 4 and 5 is associated with improved ejection fraction and may have renoprotective effects.

Event: Heart Failure 2024

Topic: Pharmacotherapy

Session: Chronic heart failure - treatment 9

Thumbnail

Unexpected acute negatively inotropic and proinflammatory effects of interleukin-11 on the myocardium

Event: Heart Failure 2023

Topic: Heart Failure

Session: ePosters in basic science 1

Thumbnail

A rare presentation of heart failure

Event: Heart Failure 2018

Topic: Multidisciplinary Interventions

Session: Clinical Case Corner 1 - Stories of women and of their broken hearts

Thumbnail

A case of bleomycin induced myocarditis

Event: Heart Failure 2018

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail